Background Urinary natural stone disease is normally common, with around prevalence

Background Urinary natural stone disease is normally common, with around prevalence among the overall population of 2% to 3%. and cost-effectiveness of tamsulosin and nifedipine in the administration of symptomatic urinary rocks. Methods/style The SUSPEND (Spontaneous Urinary Rock Passing ENabled by Medications) trial is normally a multicentre, double-blind, randomized managed trial analyzing two medical expulsive… Continue reading Background Urinary natural stone disease is normally common, with around prevalence